Advertisement
Podcast

Joan T. Merrill, MD, on Optimal Entry Criteria for Lupus Clinical Trials

08/14/2019

 

Joan T. Merrill, MD, from the Oklahoma Medical Research Foundation, discusses her research presented at the Annual European Congress of Rheumatology that evaluated different serologic features to encourage more entry in lupus clinical trials of individuals with active disease, and more.

Joan T. Merrill, MD, is director of clinical programs in the Arthritis & Clinical Immunology Research Program at the Oklahoma Medical Research Foundation in Oklahoma City, Oklahoma.

Related Content

Public Health
Public Health
William Schaffner, MD, on School-Required Immunizations and the COVID-19 Vaccines
08/20/2021
In this soundbite, William Schaffner, MD, speaks about what research on school-required immunizations says about the likelihood that parents would allow children to receive a COVID-19 vaccine, even if it is...
08/20/2021
Osteoporosis
Osteoporosis
Sonali Thosani, MD, on Bone Health Among Long-Term Cancer Survivors
09/12/2019
Dr Thosani, from The University of Texas MD Anderson Cancer Center, discusses the management of bone health among long-term cancer survivors, the importance of osteoporosis screening, and more.
09/12/2019
Immunizations
Immunizations
Greg Poland, MD, on Zoster, Pneumococcal Vaccines
01/21/2021
In this short podcast, Gregory Poland, MD, from Mayo Clinic Rochester, speaks about zoster vaccination in older adults, how it will affect them later on, and the contraindications for the vaccine.
01/21/2021
Gastroenterology
Gastroenterology
Sunanda Kane, MD, Managing Severe Ulcerative Colitis: Updated Guidelines Are Needed
11/26/2018
Dr Sunanda Kane, president of the American College of Gastroenterology, discusses current guidelines for managing severe ulcerative colitis, controversies surrounding rescue treatment, and more.
11/26/2018
Stress and Burnout
Stress and Burnout
Bruce Y. Lee, MD, on the FDA’s Emergency Authorization of Remdesivir
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020